ReviewTumor and its microenvironment: A synergistic interplay
Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the world and one of the major causes of death worldwide [1]. The prevention and the early diagnosis are surely the most important approaches for reducing the burden of CRC, given the symptoms of early disease occur just in 5% of cases. A significant portion of patients who receive surgery and adjuvant therapy still develop recurrences and metastasis and this phenomenon seems to be driven in some cell subsets by the acquisition of resistance to conventional therapy, such as chemo- and radio-therapy [2].
Growing evidence indicates that a cellular subpopulation with stem cell like features, commonly referred to as cancer stem cells (CSCs), is critical for tumor generation and maintenance.
A recent study showed that within the tumor population it is possible to identify a heterogeneous population of cells with different biological roles [3]. Recent advances in stem cell biology are revealing that this cellular fraction shares many properties with normal adult stem cells, including dormancy (quiescence), active DNA repair machinery, the expression of several ABC drugs transporters and an intrinsic resistance to apoptosis [4]. As their normal counterpart, the colon CSCs reside in a specialized microarchitectonic structures or niches that respond to both local and systemic conditions providing also protection against conventional therapies [5].
Moreover, microenvironmental stimuli, such as those involved in the epithelial-mesenchymal transition (EMT) and hypoxia, indirectly contribute to chemoresistance by inducing in cancer cells a stem like-phenotype. Understanding the driving force of tumor progression and the relationship between cancer cells and microenvironment could be fundamental in developing innovative therapeutic strategies for a better and definitive response on patient treatments.
Section snippets
CRC, stem cell niche and colon CSCs
It is widely accepted that CRC progression is driven by the acquisition of 4–5 progressive mutations in oncogenes or tumor suppressor genes [6]. Some driver mutations frequently occur in the same gene sequences and are shared by most of the people affected by this cancer, whereas some mutations are different and responsible of the final cancer phenotype in individual patients [7]. Most of the information about CRC derives from the study of familial adenomatous polyposis (FAP), an autosomal
EMT, pre-metastatic niche and metastasis formation
Metastasis formation is considered a complex multi-step process with sequential molecular and cellular events that permit transformed cells to gain access to the blood stream (intravasation), survive their journey through the blood stream, and ultimately traverse through the microvasculature of target organs (extravasation) to deposit, survive, and grow in a foreign tissue environment. The EMT represents the first step of this highly regulated cascade and it is an important biological process
Status redox and hypoxia: two sides of the same coin
In the absence of an aberrant microenvironmental stimuli, genetic and epigenetic alterations in tumor cells are insufficient to induce primary tumor progression [27]. Either through structure and function-based mechanisms, including ECM remodeling, release of cytokines and growth factors, metabolic changes, or activation of stromal components, microenvironment enables tumor cells to achieve an aggressive phenotype [32].
As observed, reactive oxygen species (ROS) have emerged as an important
CSCs and vasculature cells crosstalk: a mutual convenience
Tumor cell growth and nurture require several strategies to supply the oxygen and metabolic demand, all involving new vessels formation and captivation from the surrounding stroma. Tumor neovascularization can occur through (a) sprouting from existing vessels (sprouting angiogenesis), (b) lumen invagination and splitting of vessels (intussusceptive angiogenesis), (c) enfolding of vessels by cancer cells (vessel co-option), (d) simulation of endothelial features by tumor cells (vasculogenic
Angiogenic pathways orchestrate CSCs survival and motility
Although CSCs represent a minority of tumor cells population, deregulation of pathways involved in cell self-renewal and motility contributes to cancer conversion and promotion. In addition to well established CSCs radioresistance and chemoresistance mechanisms, an increasing adaptability to antiangiogenic treatment was shown [88]. These cells can elicit resistance and increase their tumorigenic and invasive potential by exploiting an hypoxic microenvironment [89] as well as the activation of
Therapeutic advances
Quiescent cells within the stemness niche have been associated with tumor recurrence and relapse after chemotherapy. Targeting the molecular mediators and signaling pathways affecting EMT and tumor progression may provide novel therapeutic strategies to prevent CSCs-dependent distant metastasis formation.
Fighting neovascularization to counteract cancer promotion is a crucial step of the long-standing theory of Folkman [111]. Based on this hypothesis, the first antiangiogenic compound approved
Conclusions
The reviewed data emphasize the supporting role of the microenvironment in primary tumor establishment and dissemination to distant sites. The critical event of EMT depends on the complex signals produced by stromal components ensuring the generation of CSCs phenotype with increased proliferative capacity and metastatic potential in hostile milieu. In addition, perivascular, hypoxic and premetastatic niches have been proposed to enhance the resistance of CSCs to therapy. Based on this
Conflicts of interest
None declared.
Acknowledgements
This study was supported by Grants from AIRC to G. Stassi and M. Todaro. Alice Turdo and Simone Di Franco are Ph.D. students in “International Immunopharmacology Course” at University of Palermo. Special thanks go to D. Di Franco, doctor in informatics, and Di Stefano A.B. for their cooperation in the creation of graphic images.
References (119)
- et al.
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases
Cell Stem Cell
(2011) - et al.
A genetic model for colorectal tumorigenesis
Cell
(1990) - et al.
Lessons from hereditary colorectal cancer
Cell
(1996) - et al.
Expression pattern of Wnt signaling components in the adult intestine
Gastroenterology
(2005) - et al.
Epithelial-mesenchymal transitions in development and disease
Cell
(2009) - et al.
Tumor metastasis: molecular insights and evolving paradigms
Cell
(2011) - et al.
Cancer invasion and the microenvironment: plasticity and reciprocity
Cell
(2011) - et al.
Mechanical modes of ‘amoeboid’ cell migration
Curr Opin Cell Biol
(2009) - et al.
Rho protein crosstalk: another social network
Trends Cell Biol
(2011) - et al.
Immunity, inflammation, and cancer
Cell
(2010)
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth
Cancer Cell
Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE
J Biol Chem
CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance
J Biol Chem
Hypoxia enhances colon cancer migration and invasion through promotion of epithelial-mesenchymal transition
J Surg Res
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
Cancer Cell
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4
Cell
Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways
J Biol Chem
Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1
Cancer Cell
A perivascular niche for brain tumor stem cells
Cancer Cell
Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth
Cell
Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis
Cancer Lett
Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc
J Biol Chem
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Trends Mol Med
Global cancer statistics CA
Cancer J Clin
Chemoprevention of colorectal cancer
N Engl J Med
Cancer stem cells and chemosensitivity
Clin Cancer Res
Molecular pathways: involving microenvironment damage responses in cancer therapy resistance
Clin Cancer Res
Genetic alterations during colorectal-tumor development
N Engl J Med
Familial adenomatous polyposis
Am J Gastroenterol
The ABC of APC
Hum Mol Genet
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
Nat Med
Tumour stem cells and drug resistance
Nat Rev Cancer
The distribution of secondary growths in cancer of the breast 1889
Cancer Metastasis Rev
Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps
Arch Pathol Lab Med
Myofibroblasts. II. Intestinal subepithelial myofibroblasts
Am J Physiol
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Nat Cell Biol
Identification of c-MYC as a target of the APC pathway
Science
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
Proc Natl Acad Sci USA
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
Nature
PTEN-deficient intestinal stem cells initiate intestinal polyposis
Nat Genet
Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation
J Cell Biol
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists
Biochem J
Intestinal stem cells lacking the Math1 tumour suppressor are refractory to Notch inhibitors
Nat Commun
Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma
Mol Cancer Ther
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
J Cell Biol
Tumour–stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness
Br J Cancer
mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways
Cancer Res
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression
Cancer Sci
Proteolytic interstitial cell migration: a five-step process
Cancer Metastasis Rev
Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis
J Cell Biol
Cited by (347)
The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment
2024, Computational and Structural Biotechnology JournalAutomatic segmentation of lysosomes and analysis of intracellular pH with Radachlorin photosensitizer and FLIM
2024, Biochemical and Biophysical Research CommunicationsCAFs-derived exosomes promote the development of cervical cancer by regulating miR-18a-5p-TMEM170B signaling axis
2024, Biochemical and Biophysical Research CommunicationsEffect of metabolic reprogramming on the immune microenvironment in gastric cancer
2024, Biomedicine and PharmacotherapyNIR-Triggered SrSnO<inf>3</inf> -photosynthesized nanocatalyst: A potent anticancer agent against triple negative breast cancer cells
2023, Journal of Molecular Structure
- 1
These authors contributed equally to this work.